56th Annual Meeting of the European Association for the Study of Diabetes (Virtual EASD 2020)

Ultra rapid lispro as good as lispro in reducing HbA1c

Elaine Soliven, 20201027000000

Ultra rapid lispro (URLi) was noninferior to lispro in reducing HbA_1c levels in adults with type 1 diabetes (T1D), according to the PRONTO-Pump-2* study presented at EASD 2020.

Cycling may prevent deaths in diabetes patients

Pearl Toh, 20201015143000

Cycling was associated with reduced risk for both all-cause and cardiovascular (CV) mortality in people with diabetes, according to a study presented at EASD 2020 Meeting — suggesting that cycling could be encouraged as an activity to prevent deaths in this population who are known to have a higher mortality risk than the general public.

Reducing T2D, obesity risk: Fast eaters should slow down

Audrey Abella, 20201015100000

Fast eating increases post-prandial glucose (PPG) concentration and glycaemic excursion in young, healthy women without diabetes, an interventional study has shown, thus underscoring the role of eating speed in the development of type 2 diabetes (T2D) and obesity.

Increased exercise tied to lower mortality risk in adults with T2D

Elaine Soliven, 20201015000000

Higher levels of exercise appear to be associated with a lower risk of all-cause mortality in adults with type 2 diabetes (T2D) compared with no exercise at all, according to a study presented at EASD 2020.

Rheuma drug shows disease-modifying potential for T1D

Audrey Abella, 20201014140000

Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).

Once-weekly insulin as good as once-daily dose?

Roshini Claire Anthony, 20201012190001

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Frequent hot baths tied to better health in patients with T2D

Elvira Manzano, 20201012114000

Taking regular hot baths may have a positive impact on glycaemia, blood pressure (BP), and body weight among Japanese patients with type 2 diabetes(T2D), according to a real-world study touted as the first to analyse the effect of heat therapy in T2D.

$Diabetes tied to increased fall, fracture risk$

Diabetes tied to increased fall, fracture risk

Roshini Claire Anthony, 20201009190001

The risk of falls and subsequent injuries (eg, fractures) may be elevated in individuals with diabetes compared with the general population, according to a nationwide cohort study from Denmark.

SGLT-2is show more CV benefits than GLP-1 RAs in real-world study

SGLT-2is over GLP-1 RAs for CV benefits in T2D?

Pearl Toh, 20201009143000

SGLT-2 inhibitors may confer more cardiovascular (CV) protective benefits than GLP-1 RAs in patients with type 2 diabetes (T2D), according to a real-world study presented at the EASD 2020 virtual Congress.

Detection of dysfunctional pancreatic beta cells in T1D feasible with GLP-1R imaging

Elvira Manzano, 20201007191000

Exendin-4 imaging targeting GLP-1* receptor (GLP-1R) ably detects residual, dysfunctional pancreatic beta cells in individuals with long-standing type 1 diabetes (T1D), according to a study presented at EASD 2020. This breakthrough brings research closer to the possibility of restoring insulin-producing cells depleted in T1D.